|
DESIREE 360° Breast Cancer Workshop: Relevant Outcomes on Big Data and Decision Support Systems for Cancer Management
|
|
The DESIREE team is happy to share information about its 2nd thematic stakeholder Workshop, organized in San Sebastian in July 19. With the objective to showcase the DESIREE end project technological outcomes, experiences & perspectives, they brought together:
|
|
- Clinicians from the field of oncology, including members of different tumor boards (breast, head & neck…)
- Researchers on the field of data analytics, Big Data, image analysis, computational modelling and artificial intelligence in the medical field
- Industry representatives from the IT, pharma and biomedical fields interested in incorporating these innovations in their future products or services
- Hospital managers and public policy makers willing to know the benefits of these innovations for the public health system
- DESIREE Project Consortium members
- Other participants (e.g. Physicians, Nurses)
|
|
The Workshop followed a three-fold thematic approach:
|
|
- Session 1 - DESIREE Technology Highlights and Results
- Session 2 - Clinical and Patient Perspectives
- Session 3 - Relevant Initiatives on Big Data and DSS for Oncology
|
|
Experts from the clinical and engineering arenas, from the DESIREE Consortium but also well beyond, presented advances on decision support systems, image analysis, computational modelling, as well as the clinical perspectives on the use of such systems and different related initiatives at local and international level on CDSS and Big Data for oncology. The demonstration of state-of-the-art technology by experts to an audience of interest & interrelation, to people who represent the blocks in the health technology chain, contributed to a very dynamic closing project event!
|
|
Results of the DESIREE 360° Workshop “Relevant Outcomes on Big Data and Decision Support Systems for Cancer Management” at a glance:
|
|
- DESIREE decision-support system demonstrated and exposed to a wide, cross-functional audience of experts which included end-user clinicians, members or responsible of tumor boards
- Mutually beneficial exchange and lobbying between all participating stakeholders
- Experience exchange on big data management, precision medicine, clinical decision-making practices and DSS, breast cancer management, personalized treatment patient reported outcomes and patient empowerment
- Exchange and alliances with other EU-funded projects (Big Medilytics,NUBIA, NeverMind, BD2DECIDE)
|
|
Download the detailed report in .PDF
|
|
View the full report in DESIREE website
|
|